The panel comes back. The GP reads down the column. Everything falls within the reference range. The report says normal. The patient is sent away reassured.
This scenario plays out millions of times a year. And in a meaningful proportion of those cases, the reassurance is incorrect — not because the laboratory made an error, but because the framework used to interpret the results was built for a different question than the one the patient actually needed answered.
Standard laboratory interpretation asks: is this person within the statistical range of the population we have tested? Functional medicine asks: is this person's physiology operating optimally? These are related questions, but they are not the same question. And when the gap between them is large enough, the standard report can say normal while the patient's biology is telling a completely different story.
What follows is an honest account of three things a blood panel can tell you, three things it cannot, and why the medication context changes the interpretation of almost everything.
What a blood panel actually tells you
1. Whether individual markers fall within population norms
This is what the reference range does. It is genuinely useful for identifying values that are so far outside statistical normality that they indicate acute disease or organ dysfunction. A creatinine dramatically elevated above range indicates significant kidney impairment. A haemoglobin below a certain threshold confirms clinical anaemia. A TSH above 10 indicates overt hypothyroidism. These are not ambiguous findings, and the standard range is adequate to catch them.
The limitation appears at the margins — where values sit within the range but not optimally within it. This is where the most clinically actionable information lives, and it is precisely where standard interpretation stops looking.
2. Trends across time, if you have them
A single result is a photograph. A series of results over months and years is a film. A haemoglobin of 119 g/L means different things depending on whether it has been stable at that level for three years or has dropped from 145 g/L over the past six months. The trajectory tells you something the single value cannot.
Standard care rarely maintains the longitudinal perspective needed to make this comparison in real time. Functional assessment does — because the explicit goal is to track change, not just to catch acute deviation.
3. Pattern relationships between markers
The most diagnostically useful information in a comprehensive blood panel is often not in any single value but in the relationship between multiple values. This is where functional interpretation diverges most sharply from standard practice.
Iron Status — The Pattern the Number Misses
Ferritin77 µg/L
Iron Saturation37%
TIBCElevated
Standard reportNormal
Ferritin of 77 looks adequate on a standard report. But an iron saturation of 37% — below the functional threshold of 45% — means iron is not being delivered to tissue despite adequate stores. The body is holding iron (potentially due to hepcidin elevation from chronic inflammation) but not releasing it. The number is normal. The function is not.
Thyroid — Normal Label, Subclinical Function
TSH4.26 mU/L
Free T413.9 pmol/L
Standard range0.4–5.0
Standard reportNormal
TSH of 4.26 sits within the standard reference range. But the pituitary is working hard — secreting more TSH than it would in optimal thyroid function — because the thyroid is not responding efficiently. Free T4 in the lower half of the range confirms this. The system calls it normal. The patient experiences fatigue, weight gain, cold intolerance, and declining cognitive function. Functional optimal for TSH is typically below 2.5 mU/L.
B12 — The Neurological Threshold the Lab Range Misses
Serum B12361 ng/L
Standard range180–900
MCV96 fL ↑
Standard reportNormal
Serum B12 of 361 is technically within range. But many neurologists and functional practitioners regard anything below 500 ng/L as insufficient for optimal neurological and cognitive function. The rising MCV — red cells getting larger, a classic early sign of B12 insufficiency affecting cell division — confirms that the serum level is not telling the whole story. Methylmalonic acid and homocysteine would clarify the functional picture.
01
Absorption
A result shows what is circulating in the blood. It cannot show how much of a nutrient was consumed, how much reached the gut lumen, or how much crossed the intestinal wall. A serum iron result tells you the delivery, not the supply chain. Someone taking iron tablets with a proton pump inhibitor may have adequate oral intake and negligible absorption simultaneously.
02
Tissue Delivery
Circulating levels and intracellular levels are different things. Serum magnesium can be normal while cellular magnesium is depleted — because the body maintains serum levels at the expense of tissue stores. RBC magnesium is a more reliable marker of functional status, but it is not included in standard panels and is rarely requested. The same principle applies to zinc, potassium, and B6.
03
Drug Context
A result interpreted without knowledge of the medication list is incomplete information. Statins deplete CoQ10. Metformin depletes B12. Proton pump inhibitors deplete B12, magnesium, iron, and zinc. The oral contraceptive pill depletes B6, folate, and zinc. These depletions produce results that, without context, appear to be primary deficiencies — and are treated as such, often with additional medication.
The medication context: why it changes everything
This is perhaps the most underappreciated dimension of blood test interpretation in routine clinical practice. The medication list is not a background detail. It is a primary determinant of what results mean and what is actually causing them.
| Medication |
What it depletes |
What the depletion looks like on bloods |
| Proton pump inhibitors (omeprazole, pantoprazole) |
B12, magnesium, iron, zinc, calcium |
Rising MCV, declining Hb, low serum magnesium, low ferritin or low saturation despite adequate dietary intake |
| Metformin |
B12, folate |
Elevated MCV, peripheral neuropathy attributed to diabetes rather than drug, elevated homocysteine |
| Statins (rosuvastatin, atorvastatin) |
CoQ10 |
Fatigue and muscle symptoms attributed to age rather than drug; CoQ10 not measured on standard panels |
| Oral contraceptive pill |
B6, B12, folate, zinc, magnesium, vitamin C |
Elevated homocysteine, low serum zinc, mood symptoms attributed to depression rather than methylation disruption |
| Dapagliflozin / SGLT2 inhibitors |
Fluid and electrolytes via urinary excretion |
Borderline creatinine and urea, UTI risk, weight loss — the dehydration is not reflected in a single electrolyte panel |
| Long-term corticosteroids |
Calcium, zinc, magnesium, vitamin D |
Bone density loss, immune suppression, poor wound healing — not visible on standard panels without specific testing |
The clinical consequence of missing these interactions is predictable. The depletion produces symptoms. The symptoms are presented to a clinician. The clinician does not have the framework to recognise drug-induced depletion as the cause. The symptoms are treated with an additional medication, which may itself produce further depletions. This is the prescribing cascade — a well-documented clinical phenomenon in which the side effect of one medication becomes the indication for the next.
From Clinical Practice — Without Identifying Detail
An elderly patient on a proton pump inhibitor, a statin, and an SGLT2 inhibitor simultaneously presents with progressive anaemia, rising MCV, weight loss, borderline creatinine, and worsening cognitive function. Each of these findings has a direct mechanistic link to the medication list. The PPI is blocking B12 and iron absorption. The statin is depleting CoQ10. The SGLT2 inhibitor is driving chronic low-grade dehydration that compounds the kidney picture and reduces appetite. The oral iron being prescribed for the anaemia is being taken at the same time as the PPI, which neutralises the very acid needed to absorb it. The result is a patient whose bloods are all technically within reference range, whose symptoms are attributed to age and disease progression, and who is being treated for the effects of his treatments. The intervention that would help most — B12 via a route that bypasses the blocked stomach, separation of the iron and PPI by several hours, review of whether all three drugs are still indicated — requires someone to read the list, understand the interactions, and act on the pattern rather than the individual values.
What good interpretation actually looks like
Blood chemistry interpreted functionally is not a different set of tests. It is a different set of questions applied to the same data. It asks not just whether each value falls within the population range, but where within that range it sits, what other values it is related to, what the trend looks like over time, and what the medication list, the symptom picture, and the dietary history suggest about why it looks the way it does.
A ferritin of 77 in a patient with no medications and good dietary iron intake has a different clinical meaning than a ferritin of 77 in a patient on a long-term proton pump inhibitor who is also losing small amounts of blood from aspirin-induced gastric irritation. The number is the same. The interpretation is not.
This is why the functional medicine approach to blood chemistry is not simply a different set of reference ranges. It is a different clinical framework — one that treats the result as the beginning of a question rather than the answer to one.
"A result interpreted without knowledge of the medication list is incomplete information. The medication list is not background detail — it is a primary determinant of what results mean."
Your prescription came with a patient information leaflet. It listed the side effects. It did not mention what the medication was quietly taking away — nor what that depletion would look like in your blood results two years later, or how it would be interpreted by someone who had never joined those dots.
That gap is not acceptable. It is also, in most cases, entirely bridgeable — with testing that looks at the right markers, interpretation that considers the full context, and a clinical framework built to find the pattern rather than just check the boxes.